In the news: Chinese capital market turmoil discussed, GSK scientists steal trade secrets and Shanghai’s VC compensation plan under fire

Jan 27, 2016
This week China’s stocks and capital outflows were analyzed, ex-Glaxo employees were charged with cancer drug data theft, investors criticized a local venture capital investment incentive and a probe into new-energy auto subsidies fraud began

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
 

China’s capital markets and outflows analyzed

This premium content is reserved for
China Law & Practice Subscribers.

A Premium Subscription Provides:

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment

SUBSCRIBE NOW

Subscribe Now

For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected].